These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 23235391

  • 1. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME, Braam B, Diepenbroek A, van der Putten K, Cramer MJ, Wielders JP, Swinkels DW, Doevendans PA, Gaillard CA.
    Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL.
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [Abstract] [Full Text] [Related]

  • 3. Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients.
    Malyszko J, Malyszko JS, Kozminski P, Koc-Zorawska E, Mysliwiec M, Macdougall I.
    Nephron Clin Pract; 2010 Jan; 115(4):c268-75. PubMed ID: 20424477
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
    Yılmaz I, Ozkok A, Kostek O, Kolukısa A, Duran I, Odabaş AR, Kemal Işman F, Işbilen Başok B.
    Ren Fail; 2016 Jan; 38(1):89-95. PubMed ID: 26539647
    [Abstract] [Full Text] [Related]

  • 5. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [Abstract] [Full Text] [Related]

  • 6. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S.
    Kidney Blood Press Res; 2009 Mar; 32(2):77-80. PubMed ID: 19287180
    [Abstract] [Full Text] [Related]

  • 7. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Song SH, Seong EY, Kwak IS.
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [Abstract] [Full Text] [Related]

  • 8. Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
    Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M, Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
    PLoS One; 2015 Feb; 10(7):e0132539. PubMed ID: 26161663
    [Abstract] [Full Text] [Related]

  • 9. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients.
    Bolignano D, Coppolino G, Romeo A, De Paola L, Buemi A, Lacquaniti A, Nicocia G, Lombardi L, Buemi M.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3398-403. PubMed ID: 19549696
    [Abstract] [Full Text] [Related]

  • 10. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
    Patsaoura A, Tatsi E, Margeli A, Kanavaki I, Delaporta P, Kyriakopoulou D, Kouraklis-Symeonidis A, Kattamis A, Papassotiriou I.
    Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
    [Abstract] [Full Text] [Related]

  • 11. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N.
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [Abstract] [Full Text] [Related]

  • 12. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko JS.
    Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
    [Abstract] [Full Text] [Related]

  • 13. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.
    Am J Nephrol; 2015 Jun; 41(2):156-64. PubMed ID: 25824561
    [Abstract] [Full Text] [Related]

  • 14. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA, Williams FJ, Stivers DN, Cannon L, Dixon S, Alexander P, Runyan D, David S.
    Am J Nephrol; 2012 May; 35(6):509-14. PubMed ID: 22627273
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M, Lourenço P, Dias C, Amorim M, Rema J, Leite AB, Guimarães JT, Almeida P, Bettencourt P.
    Int J Cardiol; 2013 Apr 30; 165(1):51-5. PubMed ID: 21872946
    [Abstract] [Full Text] [Related]

  • 17. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C.
    Acute Card Care; 2014 Sep 30; 16(3):93-101. PubMed ID: 24836558
    [Abstract] [Full Text] [Related]

  • 18. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K, Ricci J, Cannon L, Dixon S, Kupfer K, Stivers D, Alexander P, David S, McCullough PA.
    Ren Fail; 2015 Mar 30; 37(2):187-91. PubMed ID: 25519207
    [Abstract] [Full Text] [Related]

  • 19. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance.
    Emans ME, van der Putten K, van Rooijen KL, Kraaijenhagen RJ, Swinkels D, van Solinge WW, Cramer MJ, Doevendans PA, Braam B, Gaillard CA.
    J Card Fail; 2011 Aug 30; 17(8):626-33. PubMed ID: 21807323
    [Abstract] [Full Text] [Related]

  • 20. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
    Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Cardinal JW, Coombes JS.
    Nephrol Dial Transplant; 2012 Jan 30; 27(1):182-9. PubMed ID: 21543653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.